Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
INSP

INSP - Inspire Medical Systems Inc Stock Price, Fair Value and News

155.28USD-3.75 (-2.36%)Delayed

Market Summary

INSP
USD155.28-3.75
Delayed
-2.36%

INSP Alerts

  • 1 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

INSP Stock Price

View Fullscreen

INSP RSI Chart

INSP Valuation

Market Cap

4.6B

Price/Earnings (Trailing)

-293.22

Price/Sales (Trailing)

6.98

EV/EBITDA

-404.9

Price/Free Cashflow

1.4K

INSP Price/Sales (Trailing)

INSP Profitability

Operating Margin

97.94%

EBT Margin

-2.13%

Return on Equity

-2.67%

Return on Assets

-2.29%

Free Cashflow Yield

0.07%

INSP Fundamentals

INSP Revenue

Revenue (TTM)

660.9M

Rev. Growth (Yr)

28.24%

Rev. Growth (Qtr)

-14.8%

INSP Earnings

Earnings (TTM)

-15.7M

Earnings Growth (Yr)

35.13%

Earnings Growth (Qtr)

-167.77%

Breaking Down INSP Revenue

Last 7 days

-7.5%

Last 30 days

-36.2%

Last 90 days

-19.5%

Trailing 12 Months

-48.7%

How does INSP drawdown profile look like?

INSP Financial Health

Current Ratio

7.93

INSP Investor Care

Shares Dilution (1Y)

1.85%

Diluted EPS (TTM)

-0.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024660.9M000
2023466.4M526.1M570.2M624.8M
2022262.4M300.9M348.4M407.9M
2021134.4M175.2M201.0M233.4M
202087.1M81.3M96.3M115.4M
201956.8M63.9M71.7M82.0M
201833.3M38.2M44.0M50.6M
201719.5M22.5M25.5M28.6M
201600016.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Inspire Medical Systems Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 02, 2024
curet myriam
acquired
-
-
716
-
May 02, 2024
broader shelley g.
acquired
-
-
716
-
May 02, 2024
melenikiotou georgia
acquired
-
-
716
-
May 02, 2024
burks cynthia
acquired
-
-
716
-
May 02, 2024
mead dana g jr.
acquired
-
-
716
-
May 02, 2024
tansey casey m
acquired
-
-
716
-
May 02, 2024
ellis gary lee
acquired
-
-
716
-
May 02, 2024
mccormick shawn
acquired
-
-
716
-
Apr 29, 2024
nelson marilyn c
acquired
282,799
240
1,175
-

1–10 of 50

Which funds bought or sold INSP recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
Tidal Investments LLC
new
-
1,151,490
1,151,490
0.02%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-4.49
52,963
6,340,170
0.01%
May 16, 2024
COMERICA BANK
added
11.98
2,617,340
16,974,800
0.07%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-82.19
-10,905,800
2,525,720
-%
May 15, 2024
JANUS HENDERSON GROUP PLC
reduced
-0.01
158,797
2,925,920
-%
May 15, 2024
Novo Holdings A/S
unchanged
-
744,353
14,073,900
0.97%
May 15, 2024
Point72 Asset Management, L.P.
reduced
-44.57
-39,922,400
56,339,600
0.14%
May 15, 2024
OSTERWEIS CAPITAL MANAGEMENT INC
added
16.25
1,340,620
7,235,420
0.42%
May 15, 2024
BAMCO INC /NY/
reduced
-0.47
2,182,170
45,105,900
0.12%
May 15, 2024
MAIRS & POWER INC
reduced
-8.39
-430,418
12,713,000
0.12%

1–10 of 36

Are Funds Buying or Selling INSP?

Are funds buying INSP calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own INSP
No. of Funds

Unveiling Inspire Medical Systems Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.93%
2,931,469
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 29, 2024
blackrock inc.
6.1%
1,800,118
SC 13G/A
Nov 13, 2023
fmr llc
-
0
SC 13G
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
10.31%
2,978,391
SC 13G/A
Jan 31, 2023
blackrock inc.
7.4%
2,135,708
SC 13G/A
Nov 10, 2022
vanguard group inc
10.04%
2,899,902
SC 13G/A
Feb 03, 2022
blackrock inc.
6.7%
1,846,227
SC 13G/A
Jan 10, 2022
fmr llc
-
0
SC 13G/A

Recent SEC filings of Inspire Medical Systems Inc

View All Filings
Date Filed Form Type Document
May 13, 2024
4
Insider Trading
May 07, 2024
10-Q
Quarterly Report
May 07, 2024
8-K
Current Report
May 07, 2024
8-K
Current Report
May 06, 2024
4
Insider Trading
May 06, 2024
4
Insider Trading
May 06, 2024
4
Insider Trading
May 06, 2024
4
Insider Trading
May 06, 2024
4
Insider Trading
May 06, 2024
4
Insider Trading

Peers (Alternatives to Inspire Medical Systems Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
181.0B
40.3B
-1.75% -4.07%
32.18
4.49
-2.84% -3.08%
68.3B
19.7B
1.78% -6.05%
51.24
3.46
4.82% -17.56%
20.4B
3.9B
-9.57% -7.50%
44.2
5.22
5.72% 46.72%
18.0B
14.9B
-10.73% -18.01%
6.79
1.21
2.98% 207.68%
MID-CAP
9.8B
3.5B
6.68% 24.08%
31.27
2.76
6.16% 35.06%
9.6B
12.5B
6.31% -2.51%
24.63
0.77
-0.61% -18.83%
8.4B
2.6B
1.13% -22.65%
-26.02
3.22
-6.25% -68.62%
5.9B
3.9B
-6.79% -30.12%
-62.84
1.49
0.23% 91.03%
3.4B
387.1M
0.52% 31.17%
-216.3
8.9
30.82% 65.57%
2.3B
6.6B
0.19% -5.50%
11.93
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
5.94% -10.00%
-1.91
0.41
7.94% -1661.78%
376.6M
169.3M
-1.13% -2.23%
-4.9
2.23
7.49% -244.90%
241.9M
324.0M
-4.58% -37.15%
-1.26
0.75
-3.19% -337.41%
56.1M
50.5M
22.73% -73.49%
-2.46
1.11
14.25% -10.06%
1.1M
3.7M
-71.13% 32.26%
-0.09
0.29
5.77% 8.23%

Inspire Medical Systems Inc News

Latest updates
Defense World16 May 202407:18 am
MarketBeat13 May 202410:28 pm

Inspire Medical Systems Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-14.8%164,010,000192,508,000153,302,000151,092,000127,897,000137,900,000109,188,00091,386,00069,382,00078,398,00061,685,00052,959,00040,352,00046,009,00035,842,00012,183,00021,347,00026,906,00020,862,00018,032,00016,250,000
Gross Profit-15.3%139,253,000164,454,000128,920,000126,840,000108,009,000115,748,00089,402,00077,213,00059,378,00067,242,00053,061,00045,441,00034,371,00038,848,00030,631,00010,229,00018,050,00022,667,00017,406,00014,938,00013,396,000
Operating Expenses-0.4%154,471,000155,157,000142,391,000143,439,000127,507,000116,083,000106,596,00091,220,00075,434,00069,063,00062,857,00057,985,00050,060,00045,910,00040,523,00033,043,00034,490,00031,960,00026,057,00023,114,00022,173,000
  S&GA Expenses-100.0%-124,105,000113,247,000112,618,000101,988,00094,835,00085,603,00076,686,00063,564,00058,769,00053,243,00048,697,00041,906,00038,625,00033,216,00026,981,00029,052,00028,193,00022,434,00020,268,00019,570,000
  R&D Expenses-7.1%28,850,00031,052,00029,144,00030,821,00025,519,00021,248,00020,993,00014,534,00011,870,00010,294,0009,614,0009,288,0008,154,0007,285,0007,307,0006,062,0005,438,0003,767,0003,623,0002,846,0002,603,000
EBITDA Margin39.3%-0.02-0.03-0.05-0.07-0.08-0.10-0.13-0.13-0.15-0.17-0.22-0.25---------
Interest Expenses-------656,000494,000527,000538,000537,000530,000523,000533,000533,000526,000525,000530,000529,000523,000537,000
Income Taxes28.7%650,000505,000300,000214,000200,000146,000246,000100,000100,00031,5003,00026,000-28,00087,000--40,000---
Earnings Before Taxes-161.4%-9,355,00015,240,000-8,200,000-11,738,000-15,208,0003,275,000-16,601,000-14,348,000-16,594,000-2,371,000-10,344,000-13,062,000-16,193,000-7,456,000-10,298,000-23,089,000-16,245,000-9,040,000-8,247,000-7,650,000-8,266,000
EBT Margin33.3%-0.02-0.03-0.06-0.08-0.09-0.11-0.14-0.15-0.16-0.18-0.23-0.27---------
Net Income-167.8%-10,005,00014,763,000-8,540,000-11,952,000-15,424,0003,150,000-16,847,000-14,490,000-16,694,000-2,391,000-10,347,000-13,088,000-16,216,000-7,484,000-10,385,000-23,089,000-16,245,000-9,080,000-8,247,000-7,650,000-8,266,000
Net Income Margin29.7%-0.02-0.03-0.06-0.08-0.09-0.11-0.14-0.15-0.16-0.18-0.23-0.27---------
Free Cashflow-130.7%-2,836,0009,234,000-3,350,000237,000-5,097,00016,319,0007,490,000-7,373,000-13,963,000201,000-1,489,000-11,777,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.3%686677639618572565528292290295279272273281272271166181183186190
  Current Assets-3.6%572594570560534530496263262269255249261270267267155171170177189
    Cash Equivalents-5.5%17518633046744244241818720321421017718219117921176.0023.0048.0051.00102
  Inventory44.5%49.0034.0026.0021.0016.0012.0015.0022.0022.0017.0016.0013.0011.008.009.0010.007.006.005.004.003.00
  Net PPE30.8%52.0040.0032.0025.0021.0017.0014.0011.009.008.008.007.007.005.004.003.003.003.003.002.001.00
Liabilities-7.2%97.0010495.0089.0067.0069.0057.0065.0065.0066.0059.0052.0050.0051.0043.0038.0038.0041.0037.0033.0032.00
  Current Liabilities-7.6%72.0078.0070.0067.0060.0061.0049.0047.0043.0041.0034.0024.0019.0021.0018.0013.0014.0017.0013.009.008.00
Shareholder's Equity2.9%589573544529505496470227225229220220223230229234127140146152157
  Retained Earnings-2.9%-355-345-360-351-339-324-327-310-296-279-277-266-253-237-229-219-196-180-171-162-155
  Additional Paid-In Capital3.0%944917904881844820798538521508497487477467459453323320317315313
Accumulated Depreciation11.5%8.007.00----------------1.001.001.00
Shares Outstanding0.4%30.0030.0029.0029.0029.0029.0028.0028.0028.0027.0027.0027.00---------
Float----9,352---4,966---5,161---2,229---1,071-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-48.7%8,86017,2673,6385,092-1,34419,26911,002-5,954-12,748734-338-10,114-10,401-4,110-8,909-25,251-14,775-6,076-2,944-12,884-10,942
  Share Based Compensation15.2%26,32222,84919,82921,56718,22515,00114,58912,6599,7217,0306,8106,3415,9973,8543,3112,9032,7491,8931,5241,3891,391
Cashflow From Investing87.1%-19,535-151,723-144,2414,895-3,753-2,950-3,762-11,419-1,465-53330,149844-1,32111,396-25,92933,91967,241-19,992-501-39,02215,956
Cashflow From Financing107.6%768-10,1153,50014,9345,6317,289224,1256193,0444,0763,8433,4793,5504,5212,312126,4457878971921,241-366
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

INSP Income Statement

2024-03-31
Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 164,010$ 127,897
Cost of goods sold24,75719,888
Gross profit139,253108,009
Operating expenses:  
Research and development28,85025,519
Selling, general and administrative125,621101,988
Total operating expenses154,471127,507
Operating loss(15,218)(19,498)
Other (income) expense:  
Interest and dividend income(5,923)(4,273)
Other expense (income), net60(17)
Total other income(5,863)(4,290)
Loss before income taxes(9,355)(15,208)
Income taxes650216
Net loss(10,005)(15,424)
Other comprehensive loss:  
Foreign currency translation (loss) gain(134)105
Unrealized (loss) gain on investments(542)13
Total comprehensive loss$ (10,681)$ (15,306)
Net loss per share, basic (in dollars per share)$ (0.34)$ (0.53)
Net loss per share, diluted (in dollars per share)$ (0.34)$ (0.53)
Weighted average common shares used to compute net loss per share, basic (in shares)29,615,16629,089,950
Weighted average common shares used to compute net loss per share, diluted (in shares)29,615,16629,089,950

INSP Balance Sheet

2024-03-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 175,416$ 185,537
Investments, short-term265,945274,838
Accounts receivable, net of allowance for credit losses of $256 and $1,648, respectively72,33389,884
Inventories, net48,97433,885
Prepaid expenses and other current assets9,5469,595
Total current assets572,214593,739
Investments, long-term27,8039,143
Property and equipment, net52,28139,984
Operating lease right-of-use assets22,24822,667
Other non-current assets11,29611,278
Total assets685,842676,811
Current liabilities:  
Accounts payable43,80238,839
Accrued expenses28,37039,266
Total current liabilities72,17278,105
Operating lease liabilities, non-current portion24,50024,846
Other non-current liabilities1461,346
Total liabilities96,818104,297
Stockholders' equity:  
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding00
Common Stock, $0.001 par value per share; 200,000,000 shares authorized; 29,676,095 and 29,560,464 issued and outstanding at March 31, 2024 and December 31, 2023, respectively3030
Additional paid-in capital944,298917,107
Accumulated other comprehensive income124800
Accumulated deficit(355,428)(345,423)
Total stockholders' equity589,024572,514
Total liabilities and stockholders' equity$ 685,842$ 676,811
INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
 CEO
 WEBSITEinspiresleep.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES755

Inspire Medical Systems Inc Frequently Asked Questions


What is the ticker symbol for Inspire Medical Systems Inc? What does INSP stand for in stocks?

INSP is the stock ticker symbol of Inspire Medical Systems Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Inspire Medical Systems Inc (INSP)?

As of Fri May 17 2024, market cap of Inspire Medical Systems Inc is 4.61 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INSP stock?

You can check INSP's fair value in chart for subscribers.

What is the fair value of INSP stock?

You can check INSP's fair value in chart for subscribers. The fair value of Inspire Medical Systems Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Inspire Medical Systems Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for INSP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Inspire Medical Systems Inc a good stock to buy?

The fair value guage provides a quick view whether INSP is over valued or under valued. Whether Inspire Medical Systems Inc is cheap or expensive depends on the assumptions which impact Inspire Medical Systems Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INSP.

What is Inspire Medical Systems Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, INSP's PE ratio (Price to Earnings) is -293.22 and Price to Sales (PS) ratio is 6.98. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INSP PE ratio will change depending on the future growth rate expectations of investors.